DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 157 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $765,948 | +7.4% | 60,216 | +18.9% | 0.06% | -10.6% |
| Q2 2023 | $713,335 | +5081.9% | 50,663 | +5586.1% | 0.07% | +2100.0% |
| Q1 2023 | $13,766 | -74.0% | 891 | -68.8% | 0.00% | -66.7% |
| Q3 2022 | $53,000 | – | 2,858 | +142800.0% | 0.01% | – |
| Q2 2022 | $0 | – | 2 | -88.2% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 17 | -97.7% | 0.00% | -100.0% |
| Q4 2021 | $7,000 | – | 743 | – | 0.00% | – |
| Q2 2021 | $0 | – | 0 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $11,213,000 | 5.53% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,580,456 | $51,731,000 | 1.16% |
| ARMISTICE CAPITAL, LLC | 5,836,000 | $54,100,000 | 1.05% |
| Pinz Capital Management, LP | 165,835 | $1,537,000 | 0.96% |
| Sunesis Advisors, LLC | 96,299 | $893,000 | 0.52% |
| Redmile Group, LLC | 664,817 | $6,163,000 | 0.19% |
| PDT Partners, LLC | 222,343 | $2,061,000 | 0.18% |
| Bayesian Capital Management, LP | 41,900 | $388,000 | 0.06% |
| Laurion Capital Management LP | 459,290 | $4,258,000 | 0.05% |
| Hennion & Walsh Asset Management, Inc. | 101,643 | $942,000 | 0.05% |